REFRACTORY FOLLICULAR LYMPHOMA

This study is testing a stem cell transplant from a partially matched family donor for patients with hard-to-treat blood cancers like leukemia and lymphoma. Before the transplant, patients receive chemotherapy and radiation to wipe out their own bone marrow and cancer cells. The …

This study is testing whether combining two drugs, pirtobrutinib and mosunetuzumab, works better for people with follicular lymphoma that has returned or not responded to previous treatments. The goal is to see if this combination can kill more cancer cells and potentially reduce…

This large, late-stage trial is testing whether adding a new drug called tazemetostat to a standard two-drug treatment helps people with follicular lymphoma live longer without their cancer getting worse. The study is for adults whose lymphoma has returned or stopped responding t…

This is an early-stage study testing a new type of personalized cell therapy called MC10029 for adults with B-cell blood cancers that have come back or stopped responding to standard treatments. Researchers will first find the safest dose and then see if the therapy can shrink tu…

This study is testing whether a drug called loncastuximab tesirine can shrink tumors in adults with specific types of B-cell lymphoma that have come back or stopped responding to other treatments. The drug is designed to target cancer cells directly. Researchers will give the dru…

This early-stage study is testing a new oral medication called Q702 for patients with advanced blood cancers and rare immune cell disorders that have not responded to standard treatments. The main goals are to find the safest dose and see what side effects occur. Researchers hope…